Home Cart 0 Sign in  

[ CAS No. 4016-63-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 4016-63-1
Chemical Structure| 4016-63-1
Structure of 4016-63-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4016-63-1 ]

Related Doc. of [ 4016-63-1 ]

Alternatived Products of [ 4016-63-1 ]

Product Details of [ 4016-63-1 ]

CAS No. :4016-63-1 MDL No. :MFCD00037985
Formula : C10H12BrN5O5 Boiling Point : -
Linear Structure Formula :- InChI Key :ASUCSHXLTWZYBA-UMMCILCDSA-N
M.W : 362.14 Pubchem ID :135465599
Synonyms :
2-Amino-8-bromo-6-hydroxypurine riboside;NSC 174257;NSC 79211
Chemical Name :2-Amino-8-bromo-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one

Calculated chemistry of [ 4016-63-1 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.5
Num. rotatable bonds : 2
Num. H-bond acceptors : 7.0
Num. H-bond donors : 5.0
Molar Refractivity : 73.2
TPSA : 159.51 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.49
Log Po/w (XLOGP3) : -0.87
Log Po/w (WLOGP) : -2.24
Log Po/w (MLOGP) : -1.25
Log Po/w (SILICOS-IT) : -1.53
Consensus Log Po/w : -1.08

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.72
Solubility : 6.86 mg/ml ; 0.019 mol/l
Class : Very soluble
Log S (Ali) : -2.0
Solubility : 3.64 mg/ml ; 0.01 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.3
Solubility : 181.0 mg/ml ; 0.5 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.04

Safety of [ 4016-63-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4016-63-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4016-63-1 ]
  • Downstream synthetic route of [ 4016-63-1 ]

[ 4016-63-1 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 118-00-3 ]
  • [ 4016-63-1 ]
YieldReaction ConditionsOperation in experiment
85% With bromine In water To a suspension of guanosine 5 (4.0 g, 14.4 mmol) in water (100 mL) was added bromine (0.8 mL, 14.6 mmol) at such a rate that reaction mixture became colourless between each addition. The addition was stopped when the reaction mixture stayed slightly yellow due to unreacted bromine. The colourless solid was quickly filtered off, washed with 60 mL of cold water and 30 mL of cold acetone, recrystallized from 150 mL of hot water and dried in vacuo for 6 h at 60 °C. Yield 4.4 g (11.8 mmol, 85percent) of colourless, needle-shaped crystals 13, mp 198-200 °C; 1H NMR (400 MHz, DMSO-d6): δ 10.82 (1H, s), 6.50 (2H, s), 5.69 (1H, d, J = 6.4 Hz), 5.45 (1H, d, J = 6.0 Hz), 5.09 (1H,d, J = 5.2 Hz), 5.02 (1H, dd, J = 6.0, 11.6 Hz), 4.92 (1H, t, J= 6.0 Hz), 4.14 (1H, m), 3.86 (1H, m), 3.66 (1H, m), 3.52 (1H, m). 13C NMR (100 MHz, DMSO-d6): δ 155.5, 153.4, 152.0, 121.2, 117.5, 89.7, 85.8, 70.5, 70.3, 62.0.
51% With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione In N,N-dimethyl-formamide at 25℃; for 2.5 h; Typical procedure for the bromination of unprotected nucleosides: DBH (323 mg, 1.13 mmol) was added to a stirred solution of 1d (500 mg, 2.05 mmol) in DMF (5 mL). The resulting pale-yellow solution was stirred at room temperature for 20 minutes or until TLC showed absence of starting material and formation of less polar product. Volatiles were evaporated and the residue was coevaporated with MeCN. The resulting pale solid was crystallized from hot acetone to give 2d (500 mg, 75percent) as colorless crystals with data as reported.14
15% With sodium azide; bromoisocyanuric acid monosodium salt In water; N,N-dimethyl-formamide at 20℃; for 0.5 h; General procedure: 5'-O-Monomethoxytrityl-N2-phenoxyacetylguanosine (33, 0.138 g, 0.2 mmol) was dissolved inaqueous DMF solution (H2O:DMF 1:4, 5 mL) under stirring. SMBI (1.1 equiv., 0.051 g, 0.22 mmol)was added at r.t. and the mixture stirred. Progress of the reaction was followed by TLC. An additionalamount of the reagent (0.15 equiv., 0.007 g) was added into the reaction mixture after 1.5 h. Oncompletion of the reaction by 2 h, the reaction mixture was filtered, evaporated to dryness underreduced pressure and coevaporated with water (2 × 2 mL). The crude reaction mixture was purified bycolumn chromatography (4percent–5percent MeOH in DCM, v/v) to afford nucleoside 34 (0.148 g, 96percent) in pureform as a white solid.8-Bromo-5'-O-monomethoxytrityl-N2-phenoxyacetylguanosine (34).
Reference: [1] Photochemistry and Photobiology, 2018, vol. 94, # 4, p. 677 - 684
[2] Nucleosides, Nucleotides and Nucleic Acids, 2012, vol. 31, # 10, p. 707 - 719
[3] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2001, vol. 40, # 5, p. 382 - 385
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2002, vol. 41, # 2, p. 379 - 383
[5] Tetrahedron Letters, 2016, vol. 57, # 27-28, p. 2949 - 2953
[6] Chemistry - A European Journal, 2018, vol. 24, # 16, p. 4002 - 4005
[7] Journal of the American Chemical Society, 1995, vol. 117, # 24, p. 6439 - 6442
[8] Chemical Communications, 2008, # 2, p. 178 - 180
[9] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3333 - 3336
[10] Indian Journal of Chemistry - Section A Inorganic, Physical, Theoretical and Analytical Chemistry, 2013, vol. 52, # 8-9, p. 1004 - 1013
[11] Molecules, 2013, vol. 18, # 10, p. 12740 - 12750
[12] Structural Chemistry, 2010, vol. 21, # 1, p. 245 - 254
[13] Tetrahedron Letters, 2011, vol. 52, # 17, p. 2176 - 2180
[14] Patent: US2013/52710, 2013, A1, . Location in patent: Page/Page column
[15] Organometallics, 2018, vol. 37, # 22, p. 4181 - 4185
  • 2
  • [ 15717-45-0 ]
  • [ 4016-63-1 ]
Reference: [1] Journal of the Brazilian Chemical Society, 2010, vol. 21, # 5, p. 859 - 866
Same Skeleton Products
Historical Records